Predictions
Metabolic Explorer
Start price
Target price
Perf. (%)
€4.20
23.06.21
23.06.21
€6.00
23.06.22
23.06.22
-3.71%
24.06.22
24.06.22
Could be worthwhile Investment >10% per year
Metabolic Explorer
Start price
Target price
Perf. (%)
€0.095
22.06.21
22.06.21
€3.00
-
23.06.21
23.06.21
Could be worthwhile Investment >10% per year
Geci International
Start price
Target price
Perf. (%)
€0.015
17.06.21
17.06.21
-
17.06.22
17.06.22
-96.75%
18.06.22
18.06.22
Could be worthwhile Investment >10% per year
Egide S.A. Inh.
Start price
Target price
Perf. (%)
€1.36
08.06.21
08.06.21
€2.00
08.06.22
08.06.22
-32.62%
09.06.22
09.06.22
Could be worthwhile Investment >10% per year
Global Bioenergies
Start price
Target price
Perf. (%)
€7.10
06.06.21
06.06.21
€8.50
06.06.22
06.06.22
-28.03%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
Montagne et Neige Développement S.A.
Start price
Target price
Perf. (%)
€8.00
21.04.21
21.04.21
€12.00
21.04.22
21.04.22
-58.19%
22.04.22
22.04.22
Could be worthwhile Investment >10% per year
Euromedis Groupe
Start price
Target price
Perf. (%)
€22.15
12.04.21
12.04.21
€28.35
12.04.22
12.04.22
-51.96%
24.12.21
24.12.21
Could be worthwhile Investment >10% per year
Europlasma S.A.
Start price
Target price
Perf. (%)
€15,600
20.03.21
20.03.21
€0.000
20.03.22
20.03.22
-3.97%
03.04.21
03.04.21
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Pixium Vision S.A.
Start price
Target price
Perf. (%)
€1.03
17.02.21
17.02.21
€3.00
17.02.22
17.02.22
-24.32%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
Metabolic Explorer
Start price
Target price
Perf. (%)
€2.79
25.01.21
25.01.21
€3.10
25.01.22
25.01.22
50.36%
22.06.21
22.06.21
Could be worthwhile Investment >10% per year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€3.67
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-28.61%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
€4.00
30.10.20
30.10.20
14.26%
30.10.20
30.10.20
Probably not worthwhile Investment
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
-
04.11.21
04.11.21
-72.31%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Biocorp Production S.A.
Start price
Target price
Perf. (%)
€25.90
09.07.20
09.07.20
€25.00
04.11.21
04.11.21
11.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eurobio scientific
Start price
Target price
Perf. (%)
€7.42
06.06.20
06.06.20
€20.00
04.11.21
04.11.21
131.94%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Novacyt S.A.
Start price
Target price
Perf. (%)
€3.70
31.05.20
31.05.20
€5.00
04.11.21
04.11.21
-12.32%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€1.35
22.03.20
22.03.20
€4.00
04.11.21
04.11.21
123.70%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year